| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 1,5500% | ₹122.2 0% | 800 | ₹0.7 16.66% | 82,150231.25% |
| - | - | 820 | ₹0.85 -22.72% | 5,42575% |
| - | - | 840 | ₹1.65 -21.42% | 20,9253.84% |
| 7750% | ₹131 0% | 850 | ₹1.35 -50% | 55,025-5.33% |
| - | - | 860 | ₹1.95 -42.64% | 35,65015% |
| - | - | 870 | ₹2.5 -46.23% | 28,67532.14% |
| 1,5500% | ₹58.9 0% | 880 | ₹3.4 -41.88% | 62,775-1.21% |
| 7750% | ₹44.4 0% | 890 | ₹3.95 -48.7% | 51,15022.22% |
| 1,02,300-3.64% | ₹77.1 31.34% | 900 | ₹5.15 -46.35% | 1,84,450-16.49% |
| 25,5753.12% | ₹65.8 35.67% | 910 | ₹6.55 -45.64% | 45,725-3.27% |
| 44,950-10.76% | ₹63 48.76% | 920 | ₹8.4 -45.63% | 74,4002.12% |
| 70,525-32.08% | ₹51.5 40.32% | 930 | ₹10.6 -43.91% | 45,7250% |
| 61,225-52.12% | ₹44.15 49.15% | 940 | ₹13.6 -41.63% | 1,42,600-25.20% |
| 1,86,0001.26% | ₹38 56.05% | 950 | ₹16.25 -40.58% | 1,23,225112% |
| 1,28,650-45.21% | ₹32.2 56.69% | 960 | ₹20.55 -36.86% | 1,17,0254.86% |
| 1,59,6505.10% | ₹26.75 62.12% | 970 | ₹25.65 -32.94% | 69,7507.14% |
| 2,60,40074.09% | ₹22.5 71.1% | 980 | ₹30.8 -42.85% | 1,64,30082.75% |
| 77,5002.04% | ₹18.4 70.37% | 990 | ₹41.2 -1.19% | 31,7750% |
| 3,86,725-9.76% | ₹14.7 73.96% | 1,000 | ₹43 -39% | 1,57,32529.29% |
| 87,575318.51% | ₹12.25 85.6% | 1,010 | - | - |
| 92,22550.63% | ₹9.25 71.29% | 1,020 | ₹52.8 -12% | 8,52522.22% |
| 16,27540% | ₹7.2 77.77% | 1,030 | - | - |
| 1,44,92542.74% | ₹6 84.61% | 1,040 | - | - |
| 41,85020% | ₹4.7 84.31% | 1,050 | - | - |
| 41,850-16.92% | ₹3.7 57.44% | 1,060 | - | - |
| 51,92517.54% | ₹2.4 -4% | 1,080 | - | - |
| 1,49,5756.62% | ₹1.65 65% | 1,100 | ₹135 0% | 2,3250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
